Learn More
Apexbio Technology LLC ABT-263 (Navitoclax), 923564-51-6, MFCD12756219, 5 mg

Supplier: Apexbio Technology LLC A30075

MF: C47H55ClF3N5O6S3, MW: 974.61, Synonyms: Navitoclax, ABT-263, ABT263, ABT 263. Solubility: 48.7305mg/mL in DMSO. ABT-263 is an orally sellecitive inhibitor of B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.